Publications

Detailed Information

Korean Version of the Baylor Profound Mental Status Examination: A Brief Staging Measure for Patients with Severe Alzheimer`s Disease

DC Field Value Language
dc.contributor.authorNa, H. R.-
dc.contributor.authorLee, S. H.-
dc.contributor.authorLee, J. S.-
dc.contributor.authorDoody, R. S.-
dc.contributor.authorKim, S. Y.-
dc.date.accessioned2012-06-18T06:37:59Z-
dc.date.available2012-06-18T06:37:59Z-
dc.date.issued2009-
dc.identifier.citationDEMENTIA AND GERIATRIC COGNITIVE DISORDERS; Vol.27 1; 69-75ko_KR
dc.identifier.issn1420-8008-
dc.identifier.urihttps://hdl.handle.net/10371/77136-
dc.description.abstractBackground: The Baylor Profound Mental Status Examination (BPMSE) was modeled to provide a brief patient-derived rating scale for staging and tracking patients with severe stages of Alzheimer`s disease ( AD). Methods: The BPMSE was administered to 91 patients with probable AD ( Korean version of the MMSE less than 16) according to the National Institute of Neurological and Communicative Diseases and Stroke/Alzheimer`s Disease and Related Disorders Association criteria. The patients were also evaluated using the Korean version of the Severe Impairment Battery (SIB-Ko), Clinical Dementia Rating (CDR), Global Deterioration Scale (GDS), Barthel Activities of Daily Living (B-ADL), the Korean version of the Instrumental Activities of Daily Living (K-IADL), the Korean version of the Neuropsychiatric Inventory (K-NPI) and the Functional Assessment Staging (FAST). Results: There were significant correlations between the BPMSEKo and K-MMSE scores (r = 0.66, p < 0.001) and between the BPMSE-Ko and SIB-Ko scores (r = 0.83, p < 0.001). The BPMSE-Ko correlated with the CDR, GDS, B-ADL, K-IADL, K-NPI and FAST scores (p < 0.001). The BPMSE-Ko scores continued to decline even after the K-MMSE reached values near 0. Conclusions: The BPMSE-Ko is a time efficient and useful tool to measure cognitive function in patients with severe AD. Copyright (c) 2009 S. Karger AG, Baselko_KR
dc.description.sponsorshipThis study was supported by a grant of the Korean Health 21
R&D Project, Ministry of Health and Welfare, Republic of Korea
(A050079).
ko_KR
dc.language.isoenko_KR
dc.publisherKARGERko_KR
dc.subjectSevere dementiako_KR
dc.subjectBaylor Profound Mental Status Examinationko_KR
dc.titleKorean Version of the Baylor Profound Mental Status Examination: A Brief Staging Measure for Patients with Severe Alzheimer`s Diseaseko_KR
dc.typeArticleko_KR
dc.identifier.doi10.1159/000192585-
dc.citation.journaltitleDEMENTIA AND GERIATRIC COGNITIVE DISORDERS-
dc.description.citedreferenceNA HR, 2006, DEMENT NEUROCOGN DIS, V5, P70-
dc.description.citedreferenceAppollonio I, 2005, INT J GERIATR PSYCH, V20, P1138, DOI 10.1002/gps.1406-
dc.description.citedreferenceSaxton J, 2005, AM J GERIAT PSYCHIAT, V13, P999-
dc.description.citedreferenceFeldman H, 2005, INT J GERIATR PSYCH, V20, P559, DOI 10.1002/gps.1325-
dc.description.citedreferenceTariot PN, 2004, JAMA-J AM MED ASSOC, V291, P317-
dc.description.citedreferenceReisberg B, 2003, NEW ENGL J MED, V348, P1333-
dc.description.citedreferenceBoller F, 2002, EUR J NEUROL, V9, P125-
dc.description.citedreferenceKANG SJ, 2002, J KOREAN NEUROL ASS, V20, P8-
dc.description.citedreferenceSchmitt F, 2002, J NEURAL TRANSM-SUPP, P135-
dc.description.citedreferenceChoi SH, 2000, J KOREAN MED SCI, V15, P609-
dc.description.citedreferenceHarrell LE, 2000, ALZ DIS ASSOC DIS, V14, P168-
dc.description.citedreferenceCossa FM, 1999, BRAIN INJURY, V13, P583-
dc.description.citedreferencePippi M, 1999, AGING-CLIN EXP RES, V11, P221-
dc.description.citedreferenceDoody RS, 1999, ALZ DIS ASSOC DIS, V13, P53-
dc.description.citedreferenceKANG Y, 1997, J KOREAN NEUROL ASS, V15, P300-
dc.description.citedreferenceSchmitt FA, 1997, ALZ DIS ASSOC DIS, V11, pS51-
dc.description.citedreferencePeavy GM, 1996, ARCH NEUROL-CHICAGO, V53, P367-
dc.description.citedreferenceCUMMINGS JL, 1994, NEUROLOGY, V44, P2308-
dc.description.citedreferenceAUER SR, 1994, J AM GERIATR SOC, V42, P1266-
dc.description.citedreferenceVOLICER L, 1994, J GERONTOL, V49, pM223-
dc.description.citedreferencePANISSET M, 1994, ARCH NEUROL-CHICAGO, V51, P41-
dc.description.citedreferenceMORRIS JC, 1993, NEUROLOGY, V43, P2412-
dc.description.citedreferenceALBERT M, 1992, J AM GERIATR SOC, V40, P449-
dc.description.citedreferenceSAXTON J, 1990, PSYCHOL ASSESSMENT, V2, P298-
dc.description.citedreferenceMORRIS JC, 1989, NEUROLOGY, V39, P1159-
dc.description.citedreferenceREISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P653-
dc.description.citedreferenceCOLE MG, 1987, J CLIN EXP GERONTOL, V2, P46-
dc.description.citedreferenceMCKHANN G, 1984, NEUROLOGY, V34, P939-
dc.description.citedreferenceREISBERG B, 1982, AM J PSYCHIAT, V139, P1136-
dc.description.citedreferenceFOLSTEIN MF, 1975, J PSYCHIATR RES, V12, P198-
dc.description.citedreferenceMAHONEY FI, 1965, MD STATE MED J, V14, P61-
dc.description.tc1-
Appears in Collections:
Files in This Item:
There are no files associated with this item.

Altmetrics

Item View & Download Count

  • mendeley

Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.

Share